insights_auto
Why is PRME up 10.37%?
Dive Deeperchevron_right
PRME:NASDAQ
Prime Medicine, Inc
$3.83
arrow_upward
+10.37%(+0.36) 1D
$3.79
arrow_downward
-1.04% (-0.040)todayPre-market
Closed: Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PRME...
Open
$3.56
High
$3.87
Low
$3.49
Mkt. cap
694.67M
Avg. vol.
4.41M
Volume
330.00
52-wk high
$6.30
52-wk low
$2.67
EPS
-$1.09
Beta
2.37
Shares outstanding
181.38M
No. of employees
146
Open
$3.56
High
$3.87
Low
$3.49
Mkt. cap
694.67M
Avg. vol.
4.41M
Volume
330.00
52-wk high
$6.30
52-wk low
$2.67
EPS
-$1.09
Beta
2.37
Shares outstanding
181.38M
No. of employees
146
News stories
From web sources and news partners
FXLeaders
·
21 minutes ago
Dow Futures Gain Short-Term Momentum Clashes With US Treasury Yields
FXStreet
·
1 hour ago
S&P 500: Tech rebound offsets broader weakness – Deutsche Bank
The Motley Fool
·
27 minutes ago
IVV vs. SPY: Which S&P 500 ETF Is the Better Buy for Long-Term Investors?
Yahoo Finance
·
1 hour ago
Should You Wait Until After the Midterm Elections to Buy the S&P 500?
Profile
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts. Wikipedia
About Prime Medicine, Inc